This panel addresses current challenges and struggles for health equity under the Trump Administration. The panelists explore various aspects of health equity and the difficulties in achieving equitable aims in light of recent legislative and regulatory decisions. More specifically, panelists examine how health inequities have been exacerbated by cuts to biomedical research, mechanisms for addressing and responding to health inequities through medical-legal partnerships, and health inequities as it relates to the migrant population.
